EFFICACY AND SAFETY OF A NEW COMBINED MEDICATION WITH RECOMBINANT INTERFERON AND BETAMETHASONE IN THE TREATMENT OF HAY FEVER DURING PERIODS OF EXACERBATION

Objective: to assess the efficacy, safety and tolerability of the new combined medication Allergoferon® beta in patients with moderate-to-severe hay fever (seasonal allergic rhinitis and conjunctivitis) during periods of exacerbation. patients and methods: the object of our study was medication Alle...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: A. A. Ryabtseva, N. Y. Sotnikova, O. V. Chumikov, N. A. Stupakova
Формат: Artigo
Язык:Russo
Опубликовано: Ophthalmology Publishing Group 2016-09-01
Серии:Oftalʹmologiâ
Предметы:
hay fever
efficacy
safety
recombinant interferon
betamethasone
allergoferon® beta
Online-ссылка:https://www.ophthalmojournal.com/opht/article/view/324
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы